Profile Of Retinoblastoma Patients At H. Adam Malik RSUP 2014-2017

Dary Pallysater

Authors

Dary Pallysater Fakultas Kedokteran Universitas Sumatera Utara

Keywords:

Retinoblastoma, Clinical Characteristics, Age, Therapy

Abstract

Retinoblastoma is a malignant tumor disease of intraocular children. Retinoblastoma is caused by hereditary or non-hereditary factors. The general incidence of retinoblastoma is 1 in 15,000 births. Overall, more than two-thirds of retinoblastoma patients have unilateral tumors, the remainder have bilateral tumors. In Indonesia, the epidemiology of retinoblastoma is not known with certainty due to the lack of related research reports in the Indonesian population. The most common clinical presentation is leukocoria, followed by strabismus, pseudohypopyon, hyphema, orbital cellulitis, and vitreous hemorrhage. Aim. The purpose of this study was to determine the complete profile of retinoblastoma patients at Haji Adam Malik General Hospital in 2014-2017. Method. This research was designed in the form of a descriptive study with a retrospective research design. This research was conducted at Haji Adam Malik General Hospital. The population studied were retinoblastoma patients who were hospitalized at Haji Adam Malik General Hospital and the sample used was total sampling. The data collection method was carried out by collecting secondary data, namely medical records for the period January 2014 – July 2017, then processed with SPSS for Windows. Data analysis was carried out descriptively with frequency analysis. Results. The results showed that the incidence of retinoblastoma patients in the 2014-2017 period was 48 people, the 2-3 year age group was the largest age group (39.6%), good nutritional status was the largest group (52.1%), the most tumors were unilateral tumors. (91.7%)

References

Aerts, I., Lumbroso-Le Rouic, L., Gauthier-Villars, M., et all 2006, ‘Retinoblastoma’, Orphanet Journal of Disease, 1:31.

Al Hasan, A., Murad, R., Zaid, K., et all 2016, ‘Epidemiological Characteristics of Retinoblastoma in Childen Attending Almouassat University Hospital, Damascus, Syria, 2012-2016’, Asia-Pacific of Journal of Cancer Prevention, vol. 18, pp 421-424.

Balmer, A., Zografos, L., Munier, F. 2006, ‘ Diagnosis and Current Management of Retinoblastoma’, Oncogene, 25, pp. 5341-5349.

Bauer, J., Jurgens, H., Fruhwald, M.C. 2011, ‘Important Aspects of Nutrition in Children with Cancer’, Advances in Nutrition, Vol. 2, pp 67-77.

Bowling, B. 2016, Kanski’s Clinical Ophthalmology: A Systematic Approach, 8th edn, Elsevier Publishing, Philadelphia.

Chantada, G.L., Qaddouni, I., Canturk, S., et all 2011, ‘Strategies to Manage Retinoblastoma in Developing Countries’, Pediatric Blood Cancer, Vol. 56, pp 341-348.

Dimaras, H., Kimani, K., Dimba, E.A.O., Grondsdahl, P., et all 2012, ‘Retinoblastoma’, Lancet, 379, pp. 1436-46.

Gao, J., Zeng, J., Guo, B. et all 2016, ‘Clinical presentation and treatment outcome of retinoblastoma in children of South Western China’, Medicine, 95:42.

Garcia, M.P., Farias, M.G., Castro Junior, C.G. 2014, ‘Analysis of predictive factors of complete blood count for a high-yield hematopoietic stem cell apheresis collection’, Journal of Molecular Pathophysiology, www.scopemed.org.

Ghassemi, F., Khodabande, A. 2015, ‘Risk definition and management strategies in retinoblastoma: current prespectives’, Clinical Ophthalmology, 9, pp. 985-994.

Kemenkes 2011, Pedoman Penemuan Dini Kanker pada Anak, Depkes, Jakarta Kemenkes 2015, Panduan Nasional Penanganan Kanker Retinoblastoma, 1st edn, Depkes, Jakarta.

Kliegman, R.M., Stanton, B.F., St. Geme, J.W., Schor, N.F., Behrman, R.E. 2011, Nelson Textbook of Pediatrics, 18th edn, Elsevier Publishing, Philadelphia.

Kumar, V., Abbas, A.K., Aster, J.C. 2015, Robbins And Cotran Pathologic Basis of Disease, 9th edn, Elsevier Publishing, Philadelphia.

Lanzkowsky, P., Lipton, J.M., Fish, J.D. 2016, Lanzkowsky’s Manual of Pediatric Hematology And Oncology, 6th edn, Academic Press, London.

Luo, X., Ye, H., Ding, Y., et all 2015, ‘Clinical characteristics and prognosis of patients with retinoblastoma: 8-year follow-up’, Turkish Journal of Medical Sciences, 45, pp. 1256-1262.

Mosby, T.T., Cosgrove, M., Sarkardei, S., et all 2012, ‘Nutrition in Adult and Childhood Cancer: Role of Carcinogens and Anti-carcinogens’, Anticancer Research, Vol. 32, pp 4171-4192.

Nabie, R., Taheri, N., Fard, A.M., et all 2012, ‘Characteristics and clinical presentations of pediatric retinoblastoma in North-western Iran’, International Journal of Ophthalmology, Vol. 5 No. 4, pp 510-512.

NCI 2016, Retinoblastoma Treatment (PDQ), accessed 6 September 2017, Available at: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0032680.

Nyawira, G., Kahaki, K., Kariuki-Wanyoike, M. 2013, ‘Survival among retinoblastoma patienrs at the Kenyatta National Hospital, Kenya’, Journal of Ophthalmology of Eastern Central and Southern Africa.

Pandey, A.N. 2014, ‘Retinoblastoma: An overview’, Saudi Journal of Ophthalmology, 28, pp. 310-315.

Pudjiadi, A.H., Hegar, B., Handryastuti, S. et all 2011, Pedoman Pelayanan Medis Ikatan Dokter Anak Indonesia, 2nd edn, IDAI, Jakarta.

Rahman, A. 2014, ‘Dilema dalam Manajemen Retinoblastoma’, Majalah Kedokteran Andalas, vol. 37, n. 2.

Reddy, S.C., Anusya, S. 2010 ‘Clinical presentation of retinoblastoma in Malaysia: a review of 64 patients’, International Journal of Ophthalmology, Vol.3 No.1, pp 64-68.

Riordan-Eva, P., Cunningham., E.T. 2011, Vaughan & Ashbury’s General Opthalmology, 18th edn, Lange Mc Graw-Hill, New York.

Rodjan, F., de Graaf, P. Brisse, H.J., et all 2012, ‘Trilateral retinoblastoma : neuroimaging characteristics and value of routine brain screening on admission’, Journal of Neurooncology, 109:535-544.

Rosdiana, N. 2011, ‘Gambaran Klinis dan Laboratorium Retinoblastoma’, Sari Pediatri, vol. 12, no. 5.

Selistre, S.G.A., Maestri, M.K., Silva, P.S., et all 2016, ‘Retinoblastoma in a pediatric oncology reference center in Southern Brazil’, BMC Pediatrics, 16:48.

Shields, C.L., Fulco, E.M., Arias, J.D., et all 2013, ‘Retinoblastoma frontiers with intravenous, intraarterial, periocular, and intravitreal chemotherapy’, Eye, Vol. 27, pp 253-264.

Soebagjo, H.D., Husein, F., Notobroto, H.B., Sumitro, S.B. 2011, ‘Histopathologic Profile Grading of Haematoxylene Eosin on Retinoblastoma Stadium’, JOI, vol. 7. No. 5.

Soebagjo, H.D., Prastyani, R., Sujuti, H., et all 2013, ‘Profile of Retinoblastoma in East Java, Indonesia’, World Journal of Medicine and Medical Science Research, vol. 1 No. 3, pp. 051-056.

Soliman, S.E., Racher, H., Zhang, C. et all 2017, ‘Genetics and Molecular Diagnostics in Retinoblastoma-An Update’, Asia-Pacific Journal of Opthalmology, 6, pp. 197-207.

Suega, K., Bakta, I.M. 2011, ‘Correlation between clinical stage of solid tumor and D dimer as a marker of coagulation activation’, Acta Medica Indonesia, Vol. 43, No. 3, pp 162-167

Tehuteru, E.S. 2015, ‘Mewaspadai Gejala Kanker pada Anak’, Buletin Jendela Data dan Informasi, pp 25.